Quick Links
 
Operated by
Theme: Advanced Diagnostic & Therapeutic Approaches Towards Dementia

Testimonials

Mitchell Clionsky, Clionsky Neuro Systems

we believe that the conference proved to be a stimulating blend of many disciplines and that it created numerous opportunities for participants to broaden their awareness.

Emily Clionsky, Clionsky Neuro Systems

Based on what we saw and with whom we spoke, we are sure that you enjoyed a productive and worthwhile experience. We ask that you share your experience with your colleagues, as well as urge them to support these journals by submitting their work for publication.

Michiaki Nagai, Jichi Medical University

It was very grateful that I could participate the congress. I was very impressed because the contents of the discussion were very high quality, and I enjoyed the interesting talk with many investigators. So, I think that the conference was very high level and well organized.

Suhera Abrewal, University of Tripoli, Libya

It's been my pleasure to participate in this event, and beneficial by sharing interests with attendees and new connections.

Maria Elisa, Hospital of the Rio de Janeiro, Brazil

We have beautiful two days in San Antonio Conference.Congratulations to organized committee.

Susan Henning, DeVry University, USA

Absolutely good quality Programs, Thank you

Welcome Message

Dementia, including Alzheimer’s disease, is one of the biggest global public health challenges facing our generation. Worldwide, at least 44 million people are living with dementia this number is expected to double by 2030 and more than triple by 2050 to 115 million. In 2011, an estimated 747,000 Canadians were living with Alzheimer’s or other dementias by 2031, it is estimated that 1.4 million Canadians will have dementia. In Canada 72% of Alzheimer's sufferers are women and 62% of dementia cases are also women. Much of the increase will be in developing countries like Western Europe and North America. Already 62% of people with dementia live in developing countries. Today, over 35 million people worldwide currently live with the condition. This number is expected to double by 2030 and more than triple by 2050 to 115 million. No treatments available to slow or stop the brain damage caused by Alzheimer’s disease, several medications can temporarily help improve the symptoms of dementia for some people. In two decades, it is estimated that 1.4 million Canadians will have dementia, costing the economy almost $300 billion per year. Globally, dementia cost $600 billion a year.

Toronto is Canada's largest city, the fourth largest in North America, and home to a diverse population of about 2.8 million people. It's a global center for business, finance, arts and culture and is consistently ranked one of the world's most livable cities. The Greater Toronto Area (GTA) is a modern multicultural urban center with something for everyone. Year round, the GTA offers a unique mix of historical attractions, seasonal celebrations, family fun and a safe, walkable downtown core.

OMICS Group International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS Group is a pioneer and leading scientific event organizer, hosts over 350 leading-edge peer reviewed Open Access Journals and organizes over 100 International scientific conferences all over the globe annually with the support from over 100 International societies all around the world, with the support of 30000 editorial board members and 3 million viewers we are moving ahead to achieve our goal. OMICS Group International conferences are integrated with International workshops, symposia, trade shows in all the areas of Science, Medicine and Technology.

Renowned Speakers
Eric G. Tangalos
Mayo Clinic
USA
 
Toru Itakura
Wakayama Medical University
Japan
 
Sanjay Asthana
University of Wisconsin
USA
 
Charles De Carli
University of California
USA
Conference Highlights

Causes and Prevention of Alzheimers

Dementia: An Underlying Disease

Alzheimers Disease Diagnosis and Symptoms

Alzheimers Disease Imaging

Alzheimers Disease Pathophysiology and Disease Mechanisms

Geriatrics and Cognitive Disorder

Care Practice and Awarness

Therapeutic Targets & Mechanisms for Treatment

Animal Models and Translational Medicine

To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
Conference Date
September 23-25, 2014
Sponsors & Exhibitors
Speaker Opportunity
Day 1                Day 2                Day 3
 
Available         Available         Available
Poster Opportunity
Media Partners

The main topic of interest of this Best academic conference is Alzheimer’s Disease. Alzheimer's Disease was considered as a general term for memory loss and other brain functions severe enough to obstruct with our daily life. Alzheimer's is not a usual part of aging. But Alzheimer's is not just a disease of old age it is a progressive cerebral deterioration which has been predicted and described right through history. After many of the findings medical researchers now formally named Alzheimer's as a distinct disease and not as a normal stage of aging.

Dementia is a serious loss of global cognitive ability in a previously unimpaired person, beyond what might be expected from normal aging. It may be static, the result of a unique global brain injury, or progressive, resulting in long-term decline due to damage or disease in the body. Dementia praecox is a premature dementia also known as precocious madness. It is chronic deteriorating psychotic disorder mainly seen in late teens or early adulthood, eventually reframed into a substantially different disease concept and relabeled as schizophrenia.

Our aim is to aggregate researchers, academicians and scientists from the Alzheimer’s Disease & Dementia community and to create an avenue towards robust exchange of information on technological advances, new scientific achievements, and the effectiveness of various regulatory programs such as workshops and Symposia about Alzheimer’s Disease & Dementia.

On behalf of OMICS Publishing Group we welcome you all for this esteemed event.

Special Issues
All accepted abstracts will be published in respective OMICS Group Journals.
Each abstract will be provided with Digital Object Identifier by
Best viewed in Mozilla Firefox | Google Chrome | Opera | Safari | Above IE 7.0 version